Skip to content

The Effect of Cold Application in Patients With Rheumatoid Arthritis

The Effect of Cold Application on Pain, Disease Activity and Quality of Life in Patients With Rheumatoid Arthritis

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07359326
Enrollment
90
Registered
2026-01-22
Start date
2024-10-14
Completion date
2026-03-29
Last updated
2026-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cold Application, Disease Activity, Pain, Rheumatoid Arthritis (RA

Brief summary

The aim of this thesis is to examine the effects of cold application on pain, disease activity, and quality of life in patients with Rheumatoid Arthritis. Currently, non-pharmacological interventions, such as cold therapy, are utilized less frequently than pharmacological treatments for the management of pain in inflamed joints. Cold application is anticipated to alleviate pain and consequently enhance patients' quality of life. This study seeks to improve quality of life by reducing pain in patients with Rheumatoid Arthritis. Given its simplicity, ease of application, and low cost, this intervention may be recommended as a pain management strategy both for patients and for nurses working in clinical settings. Furthermore, the study aims to contribute to the existing literature on the subject.

Interventions

BEHAVIORALCold Application

Patients will be instructed to apply cold therapy three times daily for 15 minutes each session over a period of three weeks. Patients will report their daily cold application to the researcher via text message. For those unable to provide updates via text, the researcher will follow up daily by phone to monitor adherence to the intervention.

Sponsors

Saglik Bilimleri Universitesi
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

2 group with conventional therapy control group

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Having been diagnosed with rheumatoid arthritis at least 6 months ago, * No problems with speaking, communicating, hearing, or understanding, * Able to understand and speak Turkish, * Experiencing pain.

Exclusion criteria

* Patients who are in remission * Individuals of foreign nationality * People with psychiatric or mental illnesses * Patients who do not consent to participate in the study or who withdraw at any stage of the study

Design outcomes

Primary

MeasureTime frameDescription
Rheumatoi Arthritis Disease Activity Index-53 weeksThe Rheumatoid Arthritis Disease Activity Index-5 (RADAI-5) is a patient-reported outcome measure designed to assess disease activity in individuals with rheumatoid arthritis

Secondary

MeasureTime frameDescription
The Short Form Health Survery- SF-363 weeksThe Short Form-36 (SF-36) is a widely used generic health-related quality of life (HRQoL) questionnaire designed to assess overall physical and mental well-being. It is a self-administered instrument that evaluates health status across multiple dimensions, making it suitable for clinical practice, research, and population health surveys.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 25, 2026